Alternative splicing in prostate cancer. (2018)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41571-018-0085-0
PubMed Identifier: 30135575
Publication URI: http://europepmc.org/abstract/MED/30135575
Type: Journal Article/Review
Volume: 15
Parent Publication: Nature reviews. Clinical oncology
Issue: 11
ISSN: 1759-4774